A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers.
Nat Commun. 2022 Jan 11;13(1):217. doi: 10.1038/s41467-021-27853-w.
Nat Commun. 2022.
PMID: 35017485
Free PMC article.